يعرض 1 - 10 نتائج من 23 نتيجة بحث عن '"Kang-Fortner, Qing"', وقت الاستعلام: 1.40s تنقيح النتائج
  1. 1
    دورية أكاديمية
    CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

    المؤلفون: Mackensen, Andreas, Haanen, John B.A.G., Koenecke, Christian, Alsdorf, Winfried, Wagner-Drouet, Eva, Borchmann, Peter, Heudobler, Daniel, Ferstl, Barbara, Klobuch, Sebastian, Bokemeyer, Carsten, Desuki, Alexander, Lüke, Florian, Kutsch, Nadine, Müller, Fabian, Smit, Eveline, Hillemanns, Peter, Karagiannis, Panagiotis, Wiegert, Erol, He, Ying, Ho, Thang, Kang-Fortner, Qing, Schlitter, Anna Melissa, Schulz-Eying, Catrine, Finlayson, Andrew, Flemmig, Carina, Kühlcke, Klaus, Preußner, Liane, Rengstl, Benjamin, Türeci, Özlem, Şahin, Uğur

    المصدر: Nature Medicine ; volume 29, issue 11, page 2844-2853 ; ISSN 1078-8956 1546-170X

    مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology, General Medicine

    الإتاحة: https://doi.org/10.1038/s41591-023-02612-0Test
    https://www.nature.com/articles/s41591-023-02612-0.pdfTest
    https://www.nature.com/articles/s41591-023-02612-0Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    PB1921: A randomized, double-blind, phase 3 study of tamibarotene/azacitidine versus placebo/azacitidine in newly diagnosed adult patients selected for rara-positive HR-MDS (SELECT-MDS-1)

    المؤلفون: DeZern, Amy, Marconi, Giovanni, Deeren, Dries, Campelo, Maria Diez, Lübbert, Michael, Krishnamurthy, Pramila, Nagy, Zoltán T., Basak, Grzegorz W., Jonasova, Anna, Morozova, Elena, Geissler, Klaus, Ofran, Yishai, Kelley, Heather, Volkert, Angela, Baker, Kristen, Kang-Fortner, Qing, Hodgson, Graeme, Madigan, Catherine, Roth, David A., Kelly, Michael, Fenaux, Pierre

    المصدر: HemaSphere. - 6 (2022) , 1800-1801, ISSN: 2572-9241

    وصف الملف: pdf

    العلاقة: https://freidok.uni-freiburg.de/data/244422Test

    الإتاحة: https://doi.org/10.1097/01.hs9.0000850536.85159.f8Test
    https://freidok.uni-freiburg.de/data/244422Test
    https://nbn-resolving.org/urn:nbn:de:bsz:25-freidok-2444220Test
    https://freidok.uni-freiburg.de/dnb/download/244422Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors

    المؤلفون: Papadopoulos, Kyriakos P., Sharma, Manish R., Hamilton, Erika, Richardson, Debra, Bashir, Babar, Hodgson, Graeme, Ke, Nan, Kang-Fortner, Qing, Zhou, Li, Zamboni, William, Jolin, Hina A., Madigan, Catherine, Kelly, Michael J., Roth, David A.

    المصدر: Department of Medical Oncology Faculty Papers

    مصطلحات موضوعية: CDK7, Pharmacodynamics, POLR2A, Medicine and Health Sciences, Oncology

    وصف الملف: application/pdf

    العلاقة: https://jdc.jefferson.edu/medoncfp/134Test; https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1134&context=medoncfpTest

    الإتاحة: https://jdc.jefferson.edu/medoncfp/134Test
    https://jdc.jefferson.edu/cgi/viewcontent.cgi?article=1134&context=medoncfpTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية
    Targeting RARAoverexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML

    المؤلفون: de Botton, Stéphane, Cluzeau, Thomas, Vigil, Carlos, Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A., Liesveld, Jane L., Fenaux, Pierre, Braun, Thorsten, Banos, Anne, Jurcic, Joseph G., Sekeres, Mikkael A., Savona, Michael R., Roboz, Gail J., Bixby, Dale, Madigan, Kate, Volkert, Angela, Stephens, Kristin, Kang-Fortner, Qing, Baker, Kristen, Paul, Sofia, McKeown, Michael, Carulli, John, Eaton, Matthew, Hodgson, Graeme, Fiore, Christopher, Kelly, Michael J., Roth, David A., Stein, Eytan M.

    المصدر: Blood Advances; May 2023, Vol. 7 Issue: 9 p1858-1870, 13p

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    A randomized, double-blind, placebo-controlled study of tamibarotene/azacitidine versus placebo/azacitidine in newly diagnosed adult patients selected for RARA+ HR-MDS (SELECT-MDS-1).

    المؤلفون: Geissler, Klaus, Kelly, Michael, Roth, David A., Diez Campelo, Maria, Kelley, Heather, Dezern, Amy Elizabeth, Madigan, Catherine, Morozova, Elena, Marconi, Giovanni, Deeren, Dries, Lübbert, Michael, Krishnamurthy, Pramila, Nagy, Zsolt, Basak, Grzegorz W., Ofran, Yishai, Volkert, Angela, Baker, Kristen, Kang-Fortner, Qing, Fenaux, Pierre

    المصدر: ISSN: 1527-7755.

    العلاقة: https://freidok.uni-freiburg.de/data/244790Test

    الإتاحة: https://doi.org/10.1200/jco.2022.40.16_suppl.tps7075Test
    https://freidok.uni-freiburg.de/data/244790Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    MDS-110 SELECT-MDS-1 trial in progress: a phase 3 randomized, double-blind, placebo-controlled study of tamibarotene/azacitidine versus placebo/azacitidine in newly diagnosed adult patients selected for RARA-positive higher-risk MDS

    المؤلفون: DeZern, Amy, Fenaux, Pierre, Deeren, Dries, Campelo, Maria Diez, Lübbert, Michael, Krishnamurthy, Pramila, Nagy, Zsolt, Basak, Grzegorz W., Ová, Anna Jonáš, Geissler, Klaus, Ofran, Yishai, Volkert, Angela, Baker, Kristen, Chisholm, Jaime, Kang-Fortner, Qing, Roth, David A., Kelly, Michael, Marconi, Giovanni

    المصدر: Clinical lymphoma, myeloma & leukemia. - 22 (2022) , S303-S304, ISSN: 2152-2669

    العلاقة: https://freidok.uni-freiburg.de/data/230633Test

    الإتاحة: https://doi.org/10.1016/S2152-2650Test(22)01395-7
    https://freidok.uni-freiburg.de/data/230633Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Poster: MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-positive Higher-Risk MDS

    المؤلفون: DeZern, Amy, Fenaux, Pierre, Deeren, Dries, Campelo, Maria Diez, Lübbert, Michael, Krishnamurthy, Pramila, Nagy, Zsolt, Basak, Grzegorz, ová, Anna Jonáš, Geissler, Klaus, Ofran, Yishai, Volkert, Angela, Baker, Kristen, Chisholm, Jaime, Kang-Fortner, Qing, Roth, David A., Kelly, Michael, Marconi, Giovanni

    المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 22, page S150 ; ISSN 2152-2650

    مصطلحات موضوعية: Cancer Research, Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/s2152-2650Test(22)00912-0
    https://api.elsevier.com/content/article/PII:S2152265022009120?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2152265022009120?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RAR alpha Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

    المؤلفون: Stein, Eytan M., de Botton, Stephane, Cluzeau, Thomas, Pigneux, Arnaud, Liesveld, Jane L., Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A., Braun, Thorsten, Bixby, Dale L., Roboz, Gail J., Lebon, Delphine, Heiblig, Maël, Kelly, Michael J., Volkert, Angela, Zhou, Li, Kang-Fortner, Qing, Roth, David A., Peterlin, Pierre

    المساهمون: Département de cancérologie de l'enfant et de l'adolescent Gustave Roussy, Institut Gustave Roussy (IGR), Département d’Innovation Thérapeutique et essais précoces Gustave Roussy (DITEP), XLIM (XLIM), Université de Limoges (UNILIM)-Centre National de la Recherche Scientifique (CNRS), Biothérapies des maladies génétiques et cancers, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre Hospitalier de Versailles André Mignot (CHV), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, CHU Amiens-Picardie, HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 (HEMATIM), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), KAUST Catalysis Center (KCC), King Abdullah University of Sciences & Technologie, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)

    المصدر: ISSN: 0006-4971.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03606393; https://u-picardie.hal.science/hal-03606393Test

    الإتاحة: https://doi.org/10.1182/blood-2020-134602Test
    https://u-picardie.hal.science/hal-03606393Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية
    Selection of RARA-Positive Newly Diagnosed Unfit AML Patients with Elevated RARA Gene Expression Enriches for Features Associated with Primary Resistance to Venetoclax and Clinical Response to SY-1425, a Potent and Selective RARα Agonist, Plus Azacitidine

    المؤلفون: Fiore, Christopher, Kelly, Michael J., Volkert, Angela, Zhou, Li, Madigan, Kate, Eaton, Matthew, Hodgson, Graeme, Roth, David A., Kang-Fortner, Qing

    المصدر: Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p15-16, 2p

    النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية
    Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

    المؤلفون: Stein, Eytan M., De Botton, Stephane, Cluzeau, Thomas, Pigneux, Arnaud, Liesveld, Jane L., Cook, Rachel J., Rousselot, Philippe, Rizzieri, David A, Braun, Thorsten, Bixby, Dale L., Roboz, Gail J., Lebon, Delphine, Heiblig, Mael, Kelly, Michael J., Volkert, Angela, Zhou, Li, Kang-Fortner, Qing, Roth, David A., Peterlin, Pierre

    المصدر: Blood; November 2020, Vol. 136 Issue: Supplement 1 p6-7, 2p

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث